What Tosoh Bioscience, Inc. does

Tosoh Bioscience, Inc. is the US-based clinical diagnostics subsidiary of Tosoh Corporation, a Japanese conglomerate listed on the Tokyo Stock Exchange under ticker 4045. Founded in 1989 and headquartered in Grove City, Ohio with 132 employees, the company develops, manufactures, and distributes in-vitro diagnostic instruments and reagents to clinical laboratories across multiple specialties, with primary emphasis on diabetes testing via hemoglobin A1c measurement and secondary application in reproductive endocrinology, oncology, thyroid, cardiac, renal, metabolic, anemia, and veterinary diagnostics.

The product platform is organized around two core technology pillars. The first is HPLC (high-performance liquid chromatography) for HbA1c analysis, embodied in the HLC-723GR01 (FDA 510(k) cleared October 2025) and HLC-723G8 analyzers, which separate and quantify hemoglobin variants for diabetes diagnosis and monitoring. The second is Fluorescent Enzyme Immunoassay (FEIA), delivered through the AIA-2000 ST, AIA-900, and AIA-360 analyzers that use Tosoh's proprietary AIA-PACK dry-reagent test cups and ST biotin-free immunoassay chemistry to mitigate biotin interference. The portfolio is supported by the 501RP+ reporting middleware for data connectivity and a native integration with Sysmex laboratory automation lines that embeds the G8 into track-based high-volume workflows.

Commercially, Tosoh Bioscience operates a direct enterprise field-sales motion targeting clinical laboratories and specialty healthcare providers in the United States, complemented by event-driven demand generation at industry conferences such as ASRM 2025, content marketing, webinars, and the "Tosoh Ink" newsletter. Revenue is generated through three streams: capital-equipment sales of HPLC and immunoassay analyzers, recurring sales of proprietary AIA-PACK reagent test cups and assay consumables tied to the installed instrument base, and technical support and service contracts. Pricing is quote-based and not publicly disclosed. The US subsidiary operates as one node in Tosoh Corporation's broader bioscience footprint that also spans Europe, China, India, and Asia-Pacific.

Name

Tosoh Bioscience, Inc.

Legal name

Tosoh Bioscience, Inc.

Website

https://tosohbioscience.us

Company type

Private

Operating status

Operating

Short description

Tosoh Bioscience, Inc. is the US clinical diagnostics subsidiary of Japanese conglomerate Tosoh Corporation, selling HPLC A1c analyzers (GR01, G8) and immunoassay systems (AIA-2000/900/360) plus proprietary AIA-PACK reagent consumables to clinical laboratories in diabetes, fertility, oncology, and general chemistry segments.

Ownership category

akta.pro rank

Product category

Clinical Diagnostic Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industry

Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

Keywords

• Clinical diagnostic analyzers
• Immunoassay testing systems
• HPLC A1c testing
• Diagnostic reagent consumables
• Clinical laboratory equipment

Headquarters

HQ city

Grove City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Diagnostic Analyzers: Sale of clinical diagnostic instruments including HPLC A1c analyzers (GR01, G8) and immunoassay analyzers (AIA-2000, AIA-900, AIA-360). These are capital equipment purchases for clinical laboratories.
2. Reagent and Test Consumables: Recurring revenue from sale of proprietary test reagents, AIA-PACK test cups, and assay reagents used in Tosoh analyzers. Customers require ongoing reagent supply for continuous testing operations.
3. Technical Support and Service: Technical support and customer service for instrument maintenance, calibration, and troubleshooting. Implied through dedicated support pages and documentation services.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

Core offering

Tosoh Bioscience manufactures, sells, and services clinical diagnostic analyzers and proprietary reagents built on two core technology platforms: HPLC-based HbA1c testing systems (GR01, G8) and automated immunoassay analyzers (AIA-2000 ST, AIA-900 9 Tray Sorter, AIA-360) supported by AIA-PACK dry reagent test cups. The portfolio addresses diabetes, fertility/reproductive medicine, oncology, thyroid, cardiac, kidney, metabolic, anemia, and veterinary testing for clinical laboratories. Revenue combines capital equipment sales, recurring reagent consumables, and ongoing technical service and support.

Product overview

Tosoh Bioscience provides a comprehensive portfolio of clinical diagnostic solutions organized around two core technology platforms: HPLC A1c systems (GR01, G8) and automated immunoassay analyzers (AIA-2000 ST, AIA-900, AIA-360). These instruments are supported by AIA-PACK dry reagent technology and the 501RP+ reporting middleware. The company serves diverse clinical specialties including diabetes, reproductive/fertility, tumor markers, thyroid, anemia, cardiac, kidney, metabolic, and veterinary diagnostics. Tosoh's analyzers are designed for laboratories of varying throughput needs, from compact systems for smaller labs to high-volume integrated automation solutions.

Differentiator

Problem solved

Functional benefit

Products and services

• GR01 (HLC-723GR01) HbA1c Analyzer High-performance HPLC A1c analyzer for hemoglobin A1c testing in diabetes diagnosis and management; FDA 510(k) cleared; designed for clinical laboratories requiring accurate separation and measurement of hemoglobin variants.
• G8 (HLC-723G8) HPLC A1c Analyzer HPLC A1c analyzer designed for high-volume clinical laboratory settings, with automated workflow capabilities including Sysmex automation integration for HbA1c testing at scale.
• AIA-2000 ST Immunoassay Analyzer Automated immunoassay analyzer utilizing AIA-PACK test cup reagent technology for clinical diagnostic testing across multiple specialty areas, including tumor markers, Cystatin C, thyroid, cardiac, and metabolic panels.
• AIA-900 9 Tray Sorter Immunoassay Analyzer High-throughput immunoassay analyzer with automated sample handling and 9-tray sorter capability, designed for fertility and other specialty clinical testing applications.
• AIA-360 Immunoassay Analyzer Compact immunoassay analyzer designed for mid-to-low volume laboratories, employing proprietary AIA-PACK dry reagent technology across the Tosoh specialty test menu.
• AIA-PACK Test Cup Reagent Consumables Proprietary dry reagent test cups sold as consumables for use in AIA immunoassay analyzers, featuring fast process times, extended shelf life, and biotin-free immunoassay designs to mitigate biotin interference in test results.
• 501RP+ Reporting Middleware Reporting middleware solution that enhances data management and connectivity for Tosoh diagnostic analyzers, enabling improved data reporting and integration in clinical laboratory workflows.

Quantifiable outcome

• GR01 HbA1c Testing Analyzer provides fast, accurate results with FDA 510(k) clearance

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

One partnership is on record.

• SysmexcoreTechnology or IntegrationTosoh Bioscience has developed integration between G8 HPLC A1c analyzer and Sysmex automation systems, enabling automated workflow solutions for clinical laboratories. The partnership combines Tosoh's HPLC A1c technology with Sysmex's laboratory automation expertise.

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Direct peers

• Bio-Rad Laboratories: Bio-Rad manufactures clinical diagnostics instruments and reagents, including diabetes/HbA1c testing systems and immunoassay platforms, directly overlapping with Tosoh's HPLC A1c and immunoassay analyzer offerings.
• Trinity Biotech: Trinity Biotech is a clinical diagnostics company with a strong HbA1c (boronate affinity HPLC) product line and immunoassay offerings, directly competing with Tosoh's HPLC A1c analyzer franchise.

Broad incumbents

• Roche Diagnostics: Roche Diagnostics is a global IVD leader with cobas integrated chemistry/immunoassay platforms and HbA1c assays, competing broadly with Tosoh's analyzer and reagent offerings across hospital and reference labs.
• Abbott Diagnostics: Abbott offers the Architect/Alinity clinical chemistry and immunoassay platforms along with diabetes diagnostics, representing a major incumbent competitor to Tosoh's clinical diagnostic systems.
• Siemens Healthineers: Siemens Healthineers offers the Atellica and ADVIA Centaur clinical chemistry/immunoassay platforms that compete with Tosoh's AIA immunoassay analyzers in mid- and high-volume hospital labs.
• Beckman Coulter Diagnostics: Beckman Coulter provides DxI and Access immunoassay systems plus clinical chemistry analyzers, competing with Tosoh's AIA immunoassay product line in routine clinical laboratories.
• Ortho Clinical Diagnostics: Ortho Clinical Diagnostics (now part of QuidelOrtho) provides Vitros clinical chemistry and immunoassay systems, competing with Tosoh's AIA platform in hospital and blood bank laboratory settings.
• Agilent Technologies: Agilent is a major manufacturer of HPLC instruments and consumables used in clinical and research laboratories, broadly comparable to Tosoh's HPLC A1c technology platform.

Emerging players

• Sebia: Sebia specializes in electrophoresis and HbA1c (capillary electrophoresis) clinical diagnostics, offering an alternative platform technology to Tosoh's HPLC A1c analyzers in specialty and reference labs.

Others

• Sysmex Corporation: Sysmex is Tosoh's automation integration partner and a global leader in hematology and clinical lab automation, providing enabling instrumentation to which Tosoh's G8 analyzer connects via mutual automation partnership.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tosoh Bioscience, Inc.